实用中医内科杂志2025，Vol.39Issue(12)：28-32,5.DOI:10.13729/j.issn.1671-7813.Z25040805
基于肠道菌群探讨从脾胃论治慢性阻塞性肺疾病
Exploring the Treatment of Chronic Obstructive Pulmonary Disease from Spleen-Stomach Theory Based on intestinal Flora
摘要
Abstract
Chronic Obstructive Pulmonary Disease(COPD)is a heterogeneous disease of the lungs with persistent airflow obstruction as the main feature,and its main symptoms are recurrent chronic cough and sputum as well as gradually aggravated chest tightness,shortness of breath,and dyspnoea,which are difficult to be cured due to its prolonged and repetitive course,and it is one of the most common intractable lung diseases.Studies have shown that intestinal flora can influence the development of COPD in many aspects,such as inflammation and immunity,airway organisation,and circulatory metabolism,etc.Traditional medicine believes that the function and physiology of intestinal flora are compatible with the spleen and stomach,and spleen-enhancing drugs can improve the function of the spleen and stomach by influencing the intestinal flora,and then intervene in COPD.From the physiological and pathological relationship between COPD,intestinal flora,spleen and stomach,the paper e-laborated the specific connotation of treating COPD based on intestinal flora from the spleen-stomach theory,and found that in-testinal flora and spleen and stomach functions are similar in structure,and that the spleen and stomach can influence the pro-gression of COPD through intestinal flora,which then expanded the treatment of COPD based on the method of regulating the spleen and stomach to provide positive qi,and unimpeded qi to help the transport and transformation.This method may effective-ly improve the clinical symptoms and quality of life of COPD patients and provide new ideas for the future clinical treatment of COPD.关键词
肠道菌群/慢性阻塞性肺疾病/脾胃学说/理论探讨Key words
Intestinal flora/Chronic obstructive pulmonary disease/Spleen-stomach theory/Theoretical discussion分类
医药卫生引用本文复制引用
任若禹,于雪峰..基于肠道菌群探讨从脾胃论治慢性阻塞性肺疾病[J].实用中医内科杂志,2025,39(12):28-32,5.基金项目
国家中医药管理局人才交流中心:中医药高质量发展协同创新转化工程项目(CXZH04) （CXZH04）
